Extracorporeal Membrane Oxygenation Support in Children with Hematological Malignancies in Sweden
(2021) In Journal of Pediatric Hematology/Oncology 43(2). p.272-275- Abstract
Background: Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematological malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO. Observations: This nationwide Swedish retrospective chart review identified 958 children with hematological malignancies of whom 12 (1.3%) required ECMO support. Eight patients survived ECMO, 7 the total intensive care period, and 6 survived the underlying malignancy. Conclusions: ECMO may be considered in children with hematological malignancy. Short-term and long-term survival, in this limited group, was similar to that... (More)
Background: Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematological malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO. Observations: This nationwide Swedish retrospective chart review identified 958 children with hematological malignancies of whom 12 (1.3%) required ECMO support. Eight patients survived ECMO, 7 the total intensive care period, and 6 survived the underlying malignancy. Conclusions: ECMO may be considered in children with hematological malignancy. Short-term and long-term survival, in this limited group, was similar to that of children on ECMO at large.
(Less)
- author
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- cancer, children, ECMO, hematological malignancies
- in
- Journal of Pediatric Hematology/Oncology
- volume
- 43
- issue
- 2
- pages
- 272 - 275
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- scopus:85084326582
- pmid:32287104
- ISSN
- 1077-4114
- DOI
- 10.1097/MPH.0000000000001808
- language
- English
- LU publication?
- yes
- id
- e09d5447-7488-4d34-a46a-e44761a56483
- date added to LUP
- 2020-05-27 13:00:43
- date last changed
- 2024-09-18 23:20:48
@article{e09d5447-7488-4d34-a46a-e44761a56483, abstract = {{<p>Background: Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematological malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO. Observations: This nationwide Swedish retrospective chart review identified 958 children with hematological malignancies of whom 12 (1.3%) required ECMO support. Eight patients survived ECMO, 7 the total intensive care period, and 6 survived the underlying malignancy. Conclusions: ECMO may be considered in children with hematological malignancy. Short-term and long-term survival, in this limited group, was similar to that of children on ECMO at large.</p>}}, author = {{Ranta, Susanna and Kalzén, Håkan and Nilsson, Anna and Von Schewelov, Katarina and Broman, Lars M. and Berner, Jonas and Fläring, Urban and Norén-Nyström, Ulrika and Svahn, Johan E. and Palle, Josefine and Törnudd, Lisa and Karlsson, Lene and Mellgren, Karin and Abrahamsson, Jonas and Harila-Saari, Arja}}, issn = {{1077-4114}}, keywords = {{cancer; children; ECMO; hematological malignancies}}, language = {{eng}}, number = {{2}}, pages = {{272--275}}, publisher = {{Lippincott Williams & Wilkins}}, series = {{Journal of Pediatric Hematology/Oncology}}, title = {{Extracorporeal Membrane Oxygenation Support in Children with Hematological Malignancies in Sweden}}, url = {{http://dx.doi.org/10.1097/MPH.0000000000001808}}, doi = {{10.1097/MPH.0000000000001808}}, volume = {{43}}, year = {{2021}}, }